Literature DB >> 20550772

Inconsistent dosing of anti-tuberculosis drugs in Taipei, Taiwan.

C-Y Chiang1, K-J Bai, C-N Lee, D A Enarson, J Suo, K-T Luh.   

Abstract

SETTING: Taipei City, Taiwan.
OBJECTIVES: To evaluate prescribing practices for anti-tuberculosis drugs in the treatment of tuberculosis (TB).
METHOD: Medical audit of the medical charts of all patients notified and treated for TB in Taiwan in 2003 to determine the treatment regimens prescribed and to compare these with recommended dosages.
RESULTS: A total of 24 different anti-tuberculosis regimens were prescribed. Of 1700 patients notified, 1096 (64.5%) had their body weight recorded. Of 506 patients prescribed a three-drug fixed-dose combination (FDC), the dosage was adequate in 374 (73.9%), too low in 100 (19.8%) and too high in 32 (6.3%). Of 75 patients prescribed a two-drug FDC, the dosage was adequate in 57 (76.0%), too low in 15 (20.0%) and too high in 3 (4.0%). Of 481 patients prescribed rifampicin, the dosage was adequate in 302 (62.8%), too low in 152 (31.6%) and too high in 27 (5.6%). Of 451 patients prescribed isoniazid, the dosage was adequate in 396 (87.8%), too low in 29 (6.4%) and too high in 26 (5.8%).
CONCLUSION: The prescribing practices for anti-tuberculosis drugs were substandard and need improvement. These findings imply that the National TB Programme needs strengthening.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550772

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Adequacy of anti-tuberculosis drug prescriptions in Viet Nam.

Authors:  N B Hoa; J M Lauritsen; H L Rieder
Journal:  Public Health Action       Date:  2012-03-21

2.  European union standards for tuberculosis care.

Authors:  G B Migliori; J P Zellweger; I Abubakar; E Ibraim; J A Caminero; G De Vries; L D'Ambrosio; R Centis; G Sotgiu; O Menegale; K Kliiman; T Aksamit; D M Cirillo; M Danilovits; M Dara; K Dheda; A T Dinh-Xuan; H Kluge; C Lange; V Leimane; R Loddenkemper; L P Nicod; M C Raviglione; A Spanevello; V Ø Thomsen; M Villar; M Wanlin; J A Wedzicha; A Zumla; F Blasi; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2012-04       Impact factor: 16.671

Review 3.  Prevalence of inappropriate tuberculosis treatment regimens: a systematic review.

Authors:  M W Langendam; M J van der Werf; E Huitric; D Manissero
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

4.  Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.

Authors:  Lin Xu; Jinou Chen; Anh L Innes; Ling Li; Chen-Yuan Chiang
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

5.  Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan.

Authors:  Pin-Hui Lee; Pei-Chun Chan; Yen-Ting Peng; Po-Wei Chu; Mei-Hua Wu; Ruwen Jou; Ming-Chih Yu; Chou-Jui Lin; Yi-Wen Huang; Shun-Tien Chien; Jen-Jyh Lee; Chen-Yuan Chiang
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

6.  Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.

Authors:  Chen-Yuan Chiang; Ming-Chih Yu; Hsiu-Chen Shih; Muh-Yong Yen; Yu-Ling Hsu; Shiang-Lin Yang; Tao-Ping Lin; Kuan-Jen Bai
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

7.  Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

Authors:  Petros Isaakidis; Roma Paryani; Samsuddin Khan; Homa Mansoor; Mamta Manglani; Asmaa Valiyakath; Peter Saranchuk; Jennifer Furin
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

Review 8.  Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.

Authors:  Yuhui Xu; Jianan Wu; Sha Liao; Zhaogang Sun
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-10-03       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.